¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"adrenocortical hyperplasia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® hyperplasia ÇÑ±Û °ú´ÙÇü¼º, Áõ½Ä
¼³¸í   
  ±â´ÉÇ×ÁøÀ» À¯¹ß½Ã۴ ÀÚ±ØÀ» ¹Þ¾ÒÀ» ¶§ ºÐ¿­ÀÌ °¡´ÉÇÑ ¼¼Æ÷°¡ ¼¼Æ÷ºÐ¿­·Î ±× ¼ö°¡ Áõ°¡µÇ´Â °ÍÀ» Áõ½ÄÀ̶ó Çϸç, °á°úÀûÀ¸·Î ±× Á¶Á÷À̳ª Àå±âµµ Ä¿Áö°Ô µÈ´Ù. ºñ´ë´Â ´Ü¼øÈ÷ ¼¼Æ÷ÀÇ Áõ½ÄÀÌ ¾øÀÌ ¼¼Æ÷ÀÇ Å©±â°¡ Ä¿Áö´Â °æ¿ì¸¦ À̸£´Â ¸»ÀÌ´Ù.
¿µ¹® Benign Prostatic Hyperplasia(BPH) ÇÑ±Û Àü¸³»ùºñ´ë
¼³¸í   
  50¼¼ ÀÌ»óÀÇ ³²¼º¿¡ ºó¹ßÇϴ º´À¸·Î Àü¸³»ùÀÇ ¿äµµ ÁÖÀ§ ¿µ¿ª¿¡ Å«°áÀýÀ» Çü¼ºÇÏ¿©, À̰ÍÀÌ Ä¿Áö¸é ¿äµµ¸¦ ¾Ð¹ÚÇÏ¿© ºÎºÐÀû È¤Àº ¿ÏÀüÇÑ ¿äµµÆó»öÀ» ÀÏÀ¸Å°´Â º´ÀÌ´Ù. Áõ»óÀº ¿äµµÆó»ö¿¡ µû¸¥ ¼Òº¯ÀÇ °¨¼Ò¿Í ¹æ±¤ÀÚ±ØÁõ»óÀ¸·Î ºó´¢, ÀÜ´¢°¨, ¼Òº¯À» ÂüÀ» ¼ö ¾ø´Â Áõ»ó µîÀÌ´Ù. Ä¡·á´Â °æ¿äµµ Àü¸³»ù ÀûÃâ¼ú·Î Àü¸³¼±ÀÇ ºñ´ëÇÑ ºÎºÐÀ» ÀýÁ¦ÇؾߠÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical hyperplasia
    ºÎ½Å°ÑÁú°ú´ÙÇü¼º, ºÎ½ÅÇÇÁúÁõ½Ä
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical adenocarcinoma
    ºÎ½Å°ÑÁú»ù¾ÏÁ¾, ºÎ½ÅÇÇÁú¼±¾ÏÁ¾
  • adrenocortical hormone
    ºÎ½Å°ÑÁúÈ£¸£¸ó, ºÎ½ÅÇÇÁúÈ£¸£¸ó
  • adrenocortical insufficiency
    ºÎ½Å°ÑÁúºÎÀü, ºÎ½ÅÇÇÁúºÎÀü
  • adrenocortical steroid
    ºÎ½Å°ÑÁú½ºÅ×·ÎÀ̵å, ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • primary pigmented nodular adrenocortical disease
    ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½Å°ÑÁúº´, ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½ÅÇÇÁúº´
  • angiolymphoid hyperplasia
    Ç÷°ü¸²ÇÁ±¸°ú´ÙÇü¼º, Ç÷°ü¸²ÇÁ±¸Áõ½Ä
  • atypical adenomatous hyperplasia
    ºñÁ¤Çü»ùÁ¾Áõ½Ä
  • atypical complex hyperplasia
    ºñÁ¤Çüº¹ÇÕÀڱ󻸷Áõ½Ä
  • atypical cystic hyperplasia
    ºñÁ¤Çü³¶¼ºÁõ½Ä
  • adenomatous hyperplasia
    »ùÁ¾°ú´ÙÇü¼º
  • benign lymphoid hyperplasia
    ¾ç¼º¸²ÇÁ°ú´ÙÇü¼º
  • compensatory hyperplasia
    º¸»ó°ú´ÙÇü¼º
  • complex hyperplasia
    º¹ÇÕÁõ½Ä
  • congenital adrenal hyperplasia
    ¼±ÃµºÎ½Å°ú´ÙÇü¼º, ¼±ÃµÄáÆÏÀ§»ù°ú´ÙÇü¼º
  • cardiac myocyte hyperplasia
    ½ÉÀå±ÙÀ°¼¼Æ÷°ú´ÙÇü¼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical steroid
    ºÎ½Å°ÑÁú½ºÅ×·ÎÀ̵å, ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • hyperplasia
    °ú´ÙÇü¼º, Áõ½Ä(Áõ)
  • atypical adenomatous hyperplasia
    ºñÁ¤Çü»ùÁ¾Áõ½Ä
  • atypical complex hyperplasia
    ºñÁ¤Çüº¹ÇÕÀڱ󻸷Áõ½Ä
  • atypical cystic hyperplasia
    ºñÁ¤Çü³¶¼º½ÄÁõ
  • complex hyperplasia
    º¹ÇÕÁõ½ÄÁõ
  • congenital adrenal hyperplasia
    ¼±ÃµºÎ½Å°ú´ÙÇü¼º, ¼±ÃµÄáÆÏÀ§»ù°ú´ÙÇü¼º
  • intraductal hyperplasia
    °ü³»Áõ½Ä
  • lymphoid hyperplasia
    ¸²ÇÁ±¸Áõ½Ä
  • simple hyperplasia
    ´Ü¼øÁõ½ÄÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical hyperplasia
    ºÎ½Å°ÑÁú°ú´ÙÇü¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical hormone
    ºÎ½Å°ÑÁúÈ£¸£¸ó
  • adrenocortical insufficiency
    ºÎ½Å°ÑÁúºÎÁ·
  • adrenocortical steroid
    ºÎ½Å°ÑÁú½ºÅ×·ÎÀ̵å, ºÎ½ÅÇÇÁú½ºÅ×·ÎÀ̵å
  • adrenocortical adenocarcinoma
    ºÎ½Å°ÑÁú»ù¾ÏÁ¾
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • adenomatous hyperplasia
    »ùÁ¾°ú´ÙÇü¼º
  • adrenogenital hyperplasia
    ºÎ½Å¼º±â°ú´ÙÇü¼º
  • androgenic adrenal hyperplasia
    ¾Èµå·Î°ÕºÎ½Å°ú´ÙÇü¼º
  • angiolymphoid hyperplasia
    Ç÷°ü¸²ÇÁ±¸°ú´ÙÇü¼º
  • benign lymphoid hyperplasia
    ¾ç¼º¸²ÇÁ°ú´ÙÇü¼º
  • cardiac myocyte hyperplasia
    ½ÉÀå±ÙÀ°¼¼Æ÷°ú´ÙÇü¼º
  • compensatory hyperplasia
    º¸»ó°ú´ÙÇü¼º
  • cutaneous lymphoid hyperplasia
    ÇǺθ²ÇÁ°ú´ÙÇü¼º
  • endocervical hyperplasia
    Àڱøñ³»¸·°ú´ÙÇü¼º
  • endometrial hyperplasia
    Àڱ󻸷°ú´ÙÇü¼º, Àڱ󻸷Áõ½ÄÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenal cortical hormone =adrenocortical hormone
    ºÎ½ÅÇÇÁúÈ£¸£¸ó
  • adrenocortical adenocarcinoma
    ºÎ½ÅÇÇÁú¼±¾Ï
  • adrenocortical deficiency
    ºÎ½ÅÇÇÁú°áÇÌÁõ.
  • adrenocortical function
    ºÎ½ÅÇÇÁú±â´É.
  • adrenocortical hypofunction
    ºÎ½ÅÇÇÁú±â´ÉÀúÇÏÁõ.
  • adrenocortical insufficiency
    ºÎ½ÅÇÇÁúºÎÀüÁõ(Üùãìù«òõÝÕîïñø).
  • adrenocortical insufficiency
    ºÎ½ÅÇÇÁú ºÎÀüÁõ(¡­ù«òõÜôîîñø)
  • adrenocortical obesity
    ºÎ½ÅÇÇÁú¼º ºñ¸¸(Áõ)(¡­àõÝþØ»ñø).
  • adrenocortical steroid
    ºÎ½ÅÇÇÁú ½ºÅ×·ÎÀ̵å
  • pituitary adrenocortical insufficiency
    Çϼöü¼º ºÎ½ÅÇÇÁú(±â´É)ÀúÇÏ(Áõ)(¡­ àõÜùãìù«òõѦÒöî¸ù»ñø).
  • pituitary adrenocortical insufficiency
    Çϼöü¼º ºÎ½ÅÇÇÁú(±â´É)ÀúÇÏ(Áõ)(ù»á÷ô÷àõ Üùãìù«òõ(ѦÒö)î¸ù»(ñø))
  • Hyperplasia
    Áõ½Ä(ñòãÖ)
  • adrenal hyperplasia
    ºÎ½Å°úÇü¼º(¡­Î¦û¡à÷).
  • adrenal hyperplasia
    ºÎ½Å°úÇü¼º
  • adrenocorical hyperplasia
    ºÎ½ÅÇÇÁú °úÇü¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • congenital adrenocortical hyperplasia
    ¼±Ãµ¼º ºÎ½ÅÇÇÁú°úÇü¼º(Áõ)(¡­Üùãìù« òõΦû¡à÷ñø).
  • adrenal cortical hormone =adrenocortical hormone
    ºÎ½ÅÇÇÁúÈ£¸£¸ó
  • adrenocortical adenocarcinoma
    ºÎ½ÅÇÇÁú¼±¾Ï
  • adrenocortical deficiency
    ºÎ½ÅÇÇÁú°áÇÌÁõ.
  • adrenocortical function
    ºÎ½ÅÇÇÁú±â´É.
  • adrenocortical hypofunction
    ºÎ½ÅÇÇÁú±â´ÉÀúÇÏÁõ.
  • adrenocortical insufficiency
    ºÎ½ÅÇÇÁúºÎÀüÁõ(Üùãìù«òõÝÕîïñø).
  • adrenocortical insufficiency
    ºÎ½ÅÇÇÁú ºÎÀüÁõ(¡­ù«òõÜôîîñø)
  • adrenocortical obesity
    ºÎ½ÅÇÇÁú¼º ºñ¸¸(Áõ)(¡­àõÝþØ»ñø).
  • adrenocortical steroid
    ºÎ½ÅÇÇÁú ½ºÅ×·ÎÀ̵å
  • adrenocortical steroids
    ºÎ½ÅÇÇÁú¼º ½ºÅ×·ÎÀ̵å.
  • pituitary adrenocortical insufficiency
    Çϼöü¼º ºÎ½ÅÇÇÁú(±â´É)ÀúÇÏ(Áõ)(¡­ àõÜùãìù«òõѦÒöî¸ù»ñø).
  • pituitary adrenocortical insufficiency
    Çϼöü¼º ºÎ½ÅÇÇÁú(±â´É)ÀúÇÏ(Áõ)(ù»á÷ô÷àõ Üùãìù«òõ(ѦÒö)î¸ù»(ñø))
  • primary pigmented nodular adrenocortical disease
  • adrenal hyperplasia
    ºÎ½Å°úÇü¼º
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Total hyperplasia (Macrodactylia)
    Àüü°ú´ÙÇü¼º (Å«¼Õ°¡¶ôÁõ)
    [¿¾ ¿ë¾î] ÀüüÀû°ÅÀÎÁõ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical
    ºÎ½ÅÇÇÁúÀÇ
  • fibromuscular hyperplasia
    ¼¶À¯±Ù¼ºÁõ½ÄÁõ
  • hyperplasia
    °úÇü¼º, Áõ½Ä
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MEN Multiple Endocrine Neoplasia
  ; AD Trait
  1. MEN Type I(= Wermer Syndro...
FH facial hemihyperplasia; familial hypercholesterolemia; family history; fasting hyperbilirubinemia; f...
ACC accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst...
ACE acetonitrile; acetylcholine esterase; acute cerebral encephalopathy; acute coronary event; adrenocor...
ACH acetylcholine; achalasia; active chronic hepatitis; adrenocortical hormone; amyotrophic cerebellar h...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ACC Adrenocortical carcinoma
H-P-A Hypothalamic-pituitary-adrenocortical
HPA Hypothalamo-pituitary-adrenocortical
PPNAD Primary pigmented nodular adrenocortical disease
BAC bovine adrenocortical
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adrenocortical adenocarcinoma
    ºÎ½Å ÇÇÁú ¼±¾Ï
  • adrenocortical function
    ºÎ½Å ÇÇÁú ±â´É
    1. ½ºÅ×·ÎÀ̵å È£¸£¸óÀ» ºÐºñ. 2. ±Û·çÄÚÄÝÆ¼ÄÚÀ̵å-´ç°ú Áö¹æ ¹× ´Ü¹éÁú ´ë»ç¿¡ °ü¿©. ¹Ì³×¶ö·Î ÄÝÆ¼ÄÚÀ̵å-ü¾×°ú Na+, K+ÀÇ ´ë»ç¿¡ °ü¿©. ¾Èµå·ÎÁ¨-È¿¼ÒÀÇ °áÇÔÀ¸·Î °ú·® ÃàÀûµÇ¸é ³²¼ºÈ­¸¦ ³ªÅ¸³»´Â ³²¼º È£¸£¸ó ÀÏÁ¾.
  • adrenocortical hypofunction
    ºÎ½Å ÇÇÁú ±â´ÉÀúÇÏÁõ
  • adrenocortical obesity
    ºÎ½Å ÇÇÁú¼º ºñ¸¸, ºÎ½Å ÇÇÁú¼º ºñ¸¸Áõ
  • primary adrenocortical insuffciency
    ¿ø¹ß¼º ºÎ½Å ÇÇÁú ±â´É ºÎÀü
  • adrenal hyperplasia
    ºÎ½Å °úÇü¼º
  • adrenocorical hyperplasia
    ºÎ½Å ÇÇÁú °úÇü¼º
  • basal cell hyperplasia
    ±âÀú ¼¼Æ÷ °úÇü¼º
  • benign lymphoid hyperplasia
    ¾ç¼º ¸²ÇÁ °úÇü¼º
  • condylar hyperplasia
    ÇÏ¾Ç °úµÎ °úÇü¼ºÁõ
  • coronoid hyperplasia
    ¿ÀÈÑ µ¹±â ºñ´ë
    ÇÏ¾Ç ¿ÀÈÑ µ¹±âÀÇ ¾ç¼º °ú¼ºÀå
  • denture-induced hyperplasia
    ÀÇÄ¡¼º À°¾ÆÁ¾
    ?
  • dilantin gingival hyperplasia
    µô¶õƾ¼º Ä¡Àº Áõ½ÄÁõ
  • dilantin hyperplasia
    µô¶õƾ¼º Ä¡Àº Áõ½Ä
  • fibrous inflammatory hyperplasia
    ¼¶À¯ ¿°Áõ¼º °úÇü¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute adrenocortical insufficiency Severe adrenocortical insufficiency when an intercurrent illness or trauma causes an increased demand for adrenocortical hormones in a patient with adrenal insufficiency due to disease or use of relatively large amounts of similar hormones as therapy; characterised by nausea, vomiting, hypotension, and frequently hyperthemia, hyponatraemia, hyperkalaemia, and hypoglycaemia; can be fatal if untreated.
Synonym: addisonian crisis, adrenal crisis, Bernard-Sergent syndrome.
(05 Mar 2000)
adrenocortical Pertaining to suprarenal cortex.
(05 Mar 2000)
adrenocortical adenoma <tumour> A benign tumour of adrenal cortical cells; small unencapuslated nodules of adrenal cortex are probably localised areas of hyperplasia rather than adenoma's; true adenoma's are rare and may be symptomless or associated with Cushing's syndrome or primary aldosteronism.
(05 Mar 2000)
adrenocortical hormones Hormone's secreted by the human adrenal cortex; e.g., cortisol, aldosterone, corticosterone.
(05 Mar 2000)
adrenocortical insufficiency Loss, to varying degrees, of adrenocortical function.
Synonym: hypocorticoidism.
(05 Mar 2000)
partial adrenocortical insufficiency Normal basal adrenocortical function with failure of adrenocortical reserve to respond to ACTH stimulation.
(05 Mar 2000)
chronic adrenocortical insufficiency Adrenocortical insufficiency usually as the result of idiopathic atrophy or destruction of both adrenal glands by tuberculosis, an autoimmune process, or other diseases; characterised by fatigue, decreased blood pressure, weight loss, increased melanin pigmentation of the skin and mucous membranes, anorexia, and nausea or vomiting; without appropriate replacement therapy, it can progress to acute adrenocortical insufficiency.
Synonym: Addison's disease, addisonian syndrome, hyposupradrenalism, morbus Addisonii.
(05 Mar 2000)
primary adrenocortical insufficiency Adrenocortical insufficiency caused by disease, destruction, or surgical removal of the adrenal cortices.
(05 Mar 2000)
secondary adrenocortical insufficiency Adrenocortical insufficiency caused by failure of ACTH secretion resulting from anterior pituitary disease or inhibition of ACTH production resulting from exogenous steroid therapy.
(05 Mar 2000)
latent adrenocortical insufficiency Adrenocortical insufficiency not clinically evident but which can become severe if a sudden stress, such as an intercurrent acute illness, develops.
(05 Mar 2000)
adrenal hyperplasia <pathology> A condition of diffuse enlargement of the adrenal glands.
Origin: Gr. Plassein = to form
(27 Sep 1997)
adrenal hyperplasia, congenital A group of inherited disorders of adrenal steroidogenesis, the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect, and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form, and a 3-beta-hydroxysteroid deficiency form.
(12 Dec 1998)
angiofollicular mediastinal lymph node hyperplasia Solitary masses of lymphoid tissue containing concentric perivascular aggregates of lymphocytes, occurring usually in the mediastinum or hilar region of young adults; similar changes have been reported outside the mediastinum and, if associated with interfollicular sheets of plasma cells, may progress to lymphoma or plasmacytoma.
Synonym: angiofollicular mediastinal lymph node hyperplasia, Castleman's disease.
(05 Mar 2000)
angiolymphoid hyperplasia with eosinophilia Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells.
(12 Dec 1998)
atypical melanocytic hyperplasia Proliferation of melanocytes showing nuclear atypicality, especially as scattered single cells high in the epidermis; interpreted by some pathologists as malignant melanoma in situ.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenocortical
    ºÎ½Å ÇÇÁúÀÇ;ºÎ½Å ÇÇÁú·ÎºÎÅÍÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á